Heterozygous mutations in the telomerase components TERT the reverse transcriptase and TERC the RNA template cause autosomal dominant dyskeratosis congenita due to telomere shortening. Anticipation, whereby the disease severity increases in succeeding generations due to inheritance of shorter telomeres is a feature of this condition. Here we describe two families in which two TERT mutations are segregating. Both families contain compound heterozygotes. In one case the proband is homozygous for a novel mutation causing a P704S substitution while his father's second allele encodes a H412Y mutation. The proband in the second family has mutant alleles Y846C and H876Q.
Introduction
Mutations in genes encoding components of the telomerase ribonucleoprotein complex resulting in very short telomeres have been identified in patients with dyskeratosis congenita (DC), a rare inherited bone marrow failure syndrome. [1] [2] [3] [4] [5] [6] X-linked DC is caused by mutations in the DKC1 gene, encoding a protein necessary for the stabilization of the TERC RNA. Individuals with autosomal dominant DC (AD DC) are heterozygous for mutations in the telomerase RNA TERC or the gene encoding the catalytic subunit TERT. [2] [3] [4] [5] In contrast to patients with X-linked DC, who usually develop severe disease with a high penetrance, disease penetrance and expressivity in AD DC are highly variable and, in addition to the gene mutation, the inheritance of short telomeres is required for the manifestation of the disease. 7 , 8 Here we demonstrate that the inheritance of AD DC may be complex. We report a DC patient homozygous for a TERT mutation and compound heterozygotes in two separate families with apparent co-dominance of the two mutations.
Materials and Methods
Clinical and genetic information was obtained through our ongoing study on the molecular mechanisms of bone marrow failure (http://bmf.im.wustl.edu). The study is approved by the Washington University School of Medicine Institutional Review Board.
Informed consent was provided according to the Declaration of Helsinki. DNA for mutation analysis was extracted from peripheral blood cells (Qiagen, CA). Telomere length measurements in peripheral blood mononuclear (PBMC) by flow-FISH and direct DNA sequencing were previously described. 8 Primers used are shown in Table 1 included in supplementary data. (Invitrogen, CA). 10 In co-transfection experiments 2µg of each mutant TERT plasmid were used. Thirty-six hours after transfection telomerase activities were determined in cell lysates at protein concentrations of 40, 10, 2.5, and 0.625ng using a Q-PCR based TRAP assay as previously described.
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Results and discussion (Fig. 1A) .
Interestingly, however, the father carries a second TERT mutation in exon 2. This C1234T mutation (H412Y), has been previously described in an unrelated family. 3 This mutation reduced telomerase activity to 36% of normal in our transfection experiments 
showed that the TERT Y846C mutation was inherited from the mother, whereas the TERT H876Q mutation was inherited from her father, indicating that patient 284.1 is a compound heterozygote for the two TERT gene mutations (Fig 1A) . Both TERT gene mutations result in a significantly reduce telomerase activity after transfection into WI-38 VA-13 cells to 10% (P<0.0001) and 50% (P=0.00036) of normal ( Fig. 2A) , whereas the co-transfection of the two mutants results in a telomerase activity of 38% (P=0.004; Fig.   2B ).
Telomere length in peripheral blood cells from patient 284.1 was very short, below the 1 st percentile of normal and so were those measured in her mothers (284.2) and in one of her uncles (284.4) both of whom carry the TERT Y846C mutation. Telomere length in her father (284.3) heterozygous for the TERT H876Q mutation was between the 1 st and 5 th percentile of normal (Fig. 2C ).
In conclusion, we have identified three novel and one recurrent TERT gene mutation in two families who were thought to have sporadic DC and idiopathic aplastic anemia. All four mutations are hypomorphic mutations, impairing, but not eliminating telomerase activity. Homozygous hypomorphic TERT mutations have recently been found to cause disease in two consanguineous families. 12 Here we demonstrate that in a nonconsanguineous family compound heterozygosity for TERT can cause disease and that the involvement of TERT in the pathogenesis of DC is probably more complex than initially anticipated. Our data indicate that in compound heterozygosity or homozygosity for hypomorphic TERT mutation the mutant alleles are co-dominant and suggest that severity of telomerase dysfunction and the inheritance of short telomeres determine the clinical phenotype and onset of disease. Co-dominant inheritance has also been found in 
